|
PTP4A2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.372500000005E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6851399999962E-05 |
| Normal-vs-Stage2 |
2.166400E-01 |
| Normal-vs-Stage3 |
1.759770E-02 |
| Normal-vs-Stage4 |
8.326800E-01 |
| Stage1-vs-Stage2 |
5.062800E-01 |
| Stage1-vs-Stage3 |
4.295600E-01 |
| Stage1-vs-Stage4 |
3.946400E-01 |
| Stage2-vs-Stage3 |
8.595400E-01 |
| Stage2-vs-Stage4 |
6.251400E-01 |
| Stage3-vs-Stage4 |
5.595600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.31769999999853E-05 |
| Normal-vs-AfricanAmerican |
1.034380E-02 |
| Normal-vs-Asian |
8.319900E-02 |
| Caucasian-vs-AfricanAmerican |
5.362800E-01 |
| Caucasian-vs-Asian |
8.111400E-01 |
| AfricanAmerican-vs-Asian |
9.936000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.10599999994621E-06 |
| Normal-vs-Female |
6.117000E-01 |
| Male-vs-Female |
5.788400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.067900E-02 |
| Normal-vs-Extreme_Weight |
1.16449999643109E-08 |
| Normal-vs-Obese |
6.037900E-03 |
| Normal-vs-Extreme_Obese |
3.75559999999941E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.307190E-01 |
| Normal_Weight-vs-Obese |
9.790800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.680400E-02 |
| Extreme_Weight-vs-Obese |
2.405700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.086000E-01 |
| Obese-vs-Extreme_Obese |
2.683700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.557800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.582500E-04 |
| Normal-vs-Age(61-80Yrs) |
2.08949999999097E-05 |
| Normal-vs-Age(81-100Yrs) |
1.50284999999029E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.773020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.281610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.684200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.008200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.762180E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.173800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.80650000017424E-07 |
| Normal-VS-Type2 PRCC |
1.819250E-04 |
| Normal-VS-KIRP CIMP |
3.811700E-02 |
| Normal-VS-Unclassified PRCC |
4.560800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.778400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.318500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.600000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.319500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.112600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.144310E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.07390000000519E-05 |
| Normal-vs-N1 |
6.010600E-01 |
| Normal-vs-N2 |
6.415800E-01 |
| N0-vs-N1 |
7.992300E-02 |
| N0-vs-N2 |
3.861400E-01 |
| N1-vs-N2 |
5.820000E-01 |
|
|
